Citigroup’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Citigroup's RMD Position: Q1 2026 in Review
Citigroup increased its ResMed (RMD) stake by 54% in Q1 2026, buying an estimated $34M and bringing the position to 390,082 shares worth $87.6M. The position accounts for 0.04% of the portfolio, ranked #446.
Citigroup first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Citigroup held 390,082 shares of ResMed worth $87.6M as of Q1 2026.
- Citigroup bought 136,267 ResMed shares in Q1 2026, an estimated $34M.
- ResMed made up 0.04% of Citigroup's portfolio in Q1 2026, its #446 holding.
- Citigroup first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.